|
ZBTB33 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.538200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.347200E-01 |
| Normal-vs-Stage2 |
3.977600E-01 |
| Normal-vs-Stage3 |
2.461200E-01 |
| Normal-vs-Stage4 |
3.807000E-01 |
| Stage1-vs-Stage2 |
2.985000E-01 |
| Stage1-vs-Stage3 |
5.749800E-02 |
| Stage1-vs-Stage4 |
6.290600E-01 |
| Stage2-vs-Stage3 |
7.542400E-01 |
| Stage2-vs-Stage4 |
2.376400E-01 |
| Stage3-vs-Stage4 |
1.910620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.638800E-01 |
| Normal-vs-AfricanAmerican |
5.480800E-01 |
| Normal-vs-Asian |
6.799800E-01 |
| Caucasian-vs-AfricanAmerican |
4.525200E-01 |
| Caucasian-vs-Asian |
6.256400E-01 |
| AfricanAmerican-vs-Asian |
9.541000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.849840E-01 |
| Normal-vs-Female |
1.212070E-02 |
| Male-vs-Female |
1.242570E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.257800E-01 |
| Normal-vs-Extreme_Weight |
5.299600E-02 |
| Normal-vs-Obese |
1.942050E-01 |
| Normal-vs-Extreme_Obese |
4.011800E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.670800E-01 |
| Normal_Weight-vs-Obese |
1.695220E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.974000E-01 |
| Extreme_Weight-vs-Obese |
2.050400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.197200E-01 |
| Obese-vs-Extreme_Obese |
2.698000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.435440E-01 |
| Normal-vs-Age(41-60Yrs) |
1.573430E-01 |
| Normal-vs-Age(61-80Yrs) |
3.846000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.300550E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.283800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.320630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.968200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.476300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.823600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.621800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.607800E-01 |
| Normal-VS-Type2 PRCC |
5.869600E-01 |
| Normal-VS-KIRP CIMP |
3.176200E-01 |
| Normal-VS-Unclassified PRCC |
2.632200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.184400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.305000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.119600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.240400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.483380E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.371600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.131350E-01 |
| Normal-vs-N1 |
1.216220E-01 |
| Normal-vs-N2 |
9.112600E-01 |
| N0-vs-N1 |
2.985700E-02 |
| N0-vs-N2 |
5.568000E-01 |
| N1-vs-N2 |
5.378800E-01 |
|
|
